Lubrano E, Spadaro A. Certolizumab: efficacy and safety profile of a novel pegylatedTNF-alpha blocking agent. Acta Biomed. 2011;82(1):26-34. Accessed April 24, 2026. https://mattioli1885journals.com/index.php/actabiomedica/article/view/1362